Anti-I20RA/ IL20RA/ CRF2-8 monoclonal antibody

Anti-I20RA/ IL20RA/ CRF2-8 antibody for FACS & in-vivo assay

Target products collectionGo to IL20RA/IL20RA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0623-Ab-1/ GM-Tg-hg-MP0623-Ab-2Anti-Human IL20RA monoclonal antibodyHuman
GM-Tg-rg-MP0623-Ab-1/ GM-Tg-rg-MP0623-Ab-2Anti-Rat IL20RA monoclonal antibodyRat
GM-Tg-mg-MP0623-Ab-1/ GM-Tg-mg-MP0623-Ab-2Anti-Mouse IL20RA monoclonal antibodyMouse
GM-Tg-cynog-MP0623-Ab-1/ GM-Tg-cynog-MP0623-Ab-2Anti-Cynomolgus/ Rhesus macaque IL20RA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0623-Ab-1/ GM-Tg-felg-MP0623-Ab-2Anti-Feline IL20RA monoclonal antibodyFeline
GM-Tg-cang-MP0623-Ab-1/ GM-Tg-cang-MP0623-Ab-2Anti-Canine IL20RA monoclonal antibodyCanine
GM-Tg-bovg-MP0623-Ab-1/ GM-Tg-bovg-MP0623-Ab-2Anti-Bovine IL20RA monoclonal antibodyBovine
GM-Tg-equg-MP0623-Ab-1/ GM-Tg-equg-MP0623-Ab-2Anti-Equine IL20RA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0623-Ab-1/ GM-Tg-hg-MP0623-Ab-2; GM-Tg-rg-MP0623-Ab-1/ GM-Tg-rg-MP0623-Ab-2;
GM-Tg-mg-MP0623-Ab-1/ GM-Tg-mg-MP0623-Ab-2; GM-Tg-cynog-MP0623-Ab-1/ GM-Tg-cynog-MP0623-Ab-2;
GM-Tg-felg-MP0623-Ab-1/ GM-Tg-felg-MP0623-Ab-2; GM-Tg-cang-MP0623-Ab-1/ GM-Tg-cang-MP0623-Ab-2;
GM-Tg-bovg-MP0623-Ab-1/ GM-Tg-bovg-MP0623-Ab-2; GM-Tg-equg-MP0623-Ab-1/ GM-Tg-equg-MP0623-Ab-2
Products NameAnti-IL20RA monoclonal antibody
Formatmab
Target NameIL20RA
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL20RA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species I20RA/ IL20RA/ CRF2-8 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0623-Ag-1Interleukin 20 receptor subunit alpha (IL20RA) protein


    Target information

    Target IDGM-MP0623
    Target NameIL20RA
    Gene ID53832,237313,308716,704890,484002,101086565,509038,100073190
    Gene Symbol and SynonymsCRF2-8,E230031K19,IL-20R-alpha,IL-20R1,IL-20RA,IL20RA
    Uniprot AccessionQ9UHF4
    Uniprot Entry NameI20RA_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000016402
    Target ClassificationN/A

    The target: IL20RA, gene name: IL20RA, also named as CRF2-8, IL-20R-alpha, IL-20R1, IL-20RA. This gene encodes a member of the type II cytokine receptor family. The encoded protein is a subunit of the receptor for interleukin 20, a cytokine that may be involved in epidermal function. The interleukin 20 receptor is a heterodimeric complex consisting of the encoded protein and interleukin 20 receptor beta. This gene and interleukin 20 receptor beta are highly expressed in skin, and are upregulated in psoriasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.